about
A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivoGeneration of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo.Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice.Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological diseaseFecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.p53 involvement in the pathogenesis of fatty liver disease.Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience.Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.Donor cell leukemia with bone marrow necrosis.Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.Central nervous system infection following allogeneic hematopoietic stem cell transplantation.Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation.[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis].Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia.CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation.Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients.Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation.Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia.Erythrocytosis after allogeneic hematopoietic stem cell transplantation.Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment for Toxoplasma.[Mesenchymal stem cells for treatment of graft-versus-host disease].[Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+ T Cells in Human Colorectal Cancer.Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation.Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia.Prognostic impact of low allelic ratio ITD and mutation in acute myeloid leukemiaReassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions
P50
Q27684428-5DA04766-AD37-4AC6-8CAA-292E64118758Q34059194-784A0BD1-EBDB-4735-85D1-7BC656318C22Q34717227-F41387EA-D4AD-4AA2-BC14-FF1D3FC3E5C0Q36572920-5FDB9E61-32F6-432F-87BA-4B4848995066Q36828700-6FF4A512-3730-469C-8D3D-E65AB1AFCC73Q37376599-3B1F256A-A2A2-4EEA-B2AC-B9A6BEDF1DB7Q37508110-065DAC2F-C5F2-4F72-9F2E-CCF2FC070D9DQ38344355-5DC204F9-7006-4903-B23E-0090090A09CAQ39187325-B2D78841-F334-41EC-BCE4-244C6F3332D2Q40112657-57D3AE8B-6034-4129-B37F-8E89391D9E09Q40120334-DC3524F4-3433-4B25-BD5E-CB05D72E8E9DQ40371026-51ABC326-8C4D-4CFC-868A-7D804216272CQ40399440-73B49B82-BBCB-4F5E-8CDA-286E3E93235DQ40414162-08A080F5-321A-4D9E-87EB-87A5B99062E4Q40421080-84950786-7204-416F-8D24-366D89949A48Q40528777-AE2B9F78-3ABD-4768-95C0-F48C2728C746Q40561903-9C031BB3-3E09-4D3C-909D-979BC9D1900AQ40644980-95AFF6E4-A686-423A-ADA9-2882C9F6FD5FQ40678595-27A65E4F-0A0D-4A1D-BFFF-27AD66D0C550Q40791833-05A2C4C0-DB8E-4001-BD67-F5820BC1A654Q40973515-5E01CD20-D2EF-4168-899B-039B93887348Q41017468-4AB99E75-F4B4-4E5B-98E2-FD00AB3D4CECQ41154840-4473D7A6-CB4A-433C-BD2E-29F80FFA0841Q41457542-14E8FB6E-3039-495E-B969-B07ACCD5BABDQ41994650-ADEA4711-EBF7-4CB1-9225-D6DC400FB527Q41995146-BFC3E74D-660C-40EC-A4E3-3C49E9927852Q42174390-6EFA7535-67A1-4785-932B-DDC7CD913EFEQ44174784-BF16DF1D-ACEF-4CF5-B672-C03A59DCAFB2Q47203177-C866C0BA-BF87-401E-BF8D-D36207540946Q47228036-A244A2D4-38AE-49C4-BE68-378C1A15F3DBQ47379878-322CC91A-7647-4D94-875A-E3540E9D2417Q48351302-D899C5A2-45A6-450E-9B08-88223005A2EDQ50051269-31D69432-A030-46E2-AA5C-AF0F4FDCB0E4Q50051318-424D01C6-F71A-4773-9EA4-E8A731CB2795Q52629567-0E2809C6-F642-4AEC-B076-BC31FFA57580Q52721764-C469F314-E8B8-427A-BAAB-1CCDBB8E6AD0Q52842045-ECA1F905-1D9E-4582-BD19-89EB4B962C74Q52981533-72BFE261-93E3-4B93-B93E-84483B238108Q57795857-9053263D-677A-469C-861F-1E926CBE8A0CQ58590862-F2CD5766-6DB6-4BF0-82A6-09396A17E09B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yuho Najima
@ast
Yuho Najima
@de
Yuho Najima
@en
Yuho Najima
@es
Yuho Najima
@fr
Yuho Najima
@it
Yuho Najima
@nl
type
label
Yuho Najima
@ast
Yuho Najima
@de
Yuho Najima
@en
Yuho Najima
@es
Yuho Najima
@fr
Yuho Najima
@it
Yuho Najima
@nl
prefLabel
Yuho Najima
@ast
Yuho Najima
@de
Yuho Najima
@en
Yuho Najima
@es
Yuho Najima
@fr
Yuho Najima
@it
Yuho Najima
@nl
P106
P31
P496
0000-0001-8910-0021